Vifor Fresenius Medical Care Renal Pharma
Clinical trials sponsored by Vifor Fresenius Medical Care Renal Pharma, explained in plain language.
-
New drug shows promise for dangerous potassium levels in kidney patients
Disease control CompletedThis study tested a medicine called patiromer in 262 Chinese adults with chronic kidney disease and high potassium levels. The goal was to see if patiromer could safely lower potassium and help patients stay on important heart and kidney medications. Participants first received p…
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Dialysis itch breakthrough: new drug eases suffering in weeks
Symptom relief CompletedThis study tested a drug called difelikefalin in 260 Chinese adults on hemodialysis who had moderate-to-severe itching. Participants received either the drug or a placebo for 12 weeks, with an optional extension. The main goal was to see if the drug reduced itching intensity, mea…
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Symptom relief
Last updated May 26, 2026 12:03 UTC